Antinuclear Antibody Testing Market to Garner Revenue of $2,766 million and CAGR of 13.0% in 2019-2027 - Exclusive Report [247 pages] by Research Dive

Source :: PR Newswire. December 9, 2020
Publication Year :: 2020
Abstract: The antinuclear antibody testing market will grow in the coming years. The reagents & assay kits sub-segment will be the most profitable. Rheumatoid arthritis sub-segment will be the most lucrative [...]

Subjects :: Systemic scleroderma -- Reports -- Forecasts and trends
Rheumatoid factor -- Reports -- Forecasts and trends
Biological products -- Reports -- Forecasts and trends
Scleroderma (Disease) -- Reports -- Forecasts and trends
Immunofluorescence -- Forecasts and trends -- Reports
Systemic lupus erythematosus -- Forecasts and trends -- Reports
Arthritis -- Reports -- Forecasts and trends
Fluorescent antibody technique -- Forecasts and trends -- Reports
Medical laboratories -- Forecasts and trends -- Reports
Medical offices -- Reports -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools